{
  "meta": {
    "strategy": "baseline-probe + shard-sweeps(GET)",
    "elapsed_sec": 514.78,
    "rows": 25,
    "request_sleep": 0.03,
    "max_depth": 1,
    "target_min_rows": 2000,
    "max_rows": 5000
  },
  "rows": [
    {
      "Status": "Dormant",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18029",
      "DIN": "02023709",
      "Company": "PHARMA STULLN INC.",
      "Product": "BALANCED SALT SOLUTION",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "6",
      "A.I. name See footnote3": "CALCIUM CHLORIDE",
      "Strength": "0.48 MG / ML",
      "Current status date": "2019-09-30",
      "Original market date": "1994-12-31",
      "Address": "6500 Trans Canada Highway, Suite 400",
      "City": "Pointe-Claire",
      "state": "Quebec",
      "Country": "Canada",
      "Zipcode": "H9R 0A5",
      "Number of active ingredient(s)": "6",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:36.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05CB10 COMBINATIONS",
      "Active ingredient group (AIG) number": "0600055001",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "CALCIUM CHLORIDE : 0.48 MG / ML\nMAGNESIUM CHLORIDE : 0.3 MG / ML\nPOTASSIUM CHLORIDE : 0.75 MG / ML\nSODIUM ACETATE : 3.9 MG / ML\nSODIUM CHLORIDE : 6.4 MG / ML\nSODIUM CITRATE : 1.7 MG / ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Irrigation",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18029\",\"02023709\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14114",
      "DIN": "02008580",
      "Company": "3 WAY HERBS LTD.",
      "Product": "#17 DIURETIC TEA",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "NON-PRESCRIPTION DRUGS",
      "# See footnote2": "9",
      "A.I. name See footnote3": "FENNEL",
      "Strength": "136 MG / 5 ML",
      "Current status date": "2001-08-03",
      "Original market date": "1993-12-31",
      "Address": "Castlegar",
      "City": "British Columbia",
      "state": "Canada",
      "Country": "V1N 3H4",
      "Zipcode": "",
      "Number of active ingredient(s)": "9",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "92:01.00* \n See footnote 6",
      "Anatomical Therapeutic Chemical (ATC)": "",
      "Active ingredient group (AIG) number": "0924050001",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "COUCH GRASS : 136 MG / 5 ML\nFENNEL : 136 MG / 5 ML\nGOOSE GRASS : 136 MG / 5 ML\nJUNIPER BERRIES : 136 MG / 5 ML\nPARSLEY : 136 MG / 5 ML\nSHEPHERDS PURSE : 136 MG / 5 ML\nTARAXACUM OFFICINALE WEBER : 136 MG / 5 ML\nUVA URSI : 136 MG / 5 ML\nZEA MAYS : 136 MG / 5 ML",
      "Dosage form": "Tea (Herbal)",
      "Route(s) of administration": "Oral",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14114\",\"02008580\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14096",
      "DIN": "01996878",
      "Company": "3 WAY HERBS LTD.",
      "Product": "#7 NERVE TEA",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "NON-PRESCRIPTION DRUGS",
      "# See footnote2": "9",
      "A.I. name See footnote3": "CHAMOMILE",
      "Strength": "16 %",
      "Current status date": "2001-08-03",
      "Original market date": "1993-12-31",
      "Address": "Castlegar",
      "City": "British Columbia",
      "state": "Canada",
      "Country": "V1N 3H4",
      "Zipcode": "",
      "Number of active ingredient(s)": "9",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "92:01.00* \n See footnote 6",
      "Anatomical Therapeutic Chemical (ATC)": "",
      "Active ingredient group (AIG) number": "0948751001",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "CHAMOMILE : 16 %\nHOPS : 4 %\nMOTHERWORT COMMON : 10 %\nMUGWORT : 8 %\nPASSION FLOWER : 16 %\nROSMARINUS OFFICINALIS : 4 %\nSCULLCAP : 4 %\nVALERIAN : 8 %\nVERBENA OFFICINALIS : 8 %",
      "Dosage form": "Tea (Herbal)",
      "Route(s) of administration": "Oral",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=14096\",\"01996878\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3132",
      "DIN": "00438014",
      "Company": "BAXTER CORPORATION",
      "Product": "(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "3.3 G / 100 ML",
      "Current status date": "2013-01-21",
      "Original market date": "1978-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00 \n \n \n \n , \n \n \n \n \n \n 40:20.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097026",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00034399.PDF",
      "Product Monograph/Veterinary Date": "2016-04-07",
      "List of active ingredient": "DEXTROSE : 3.3 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 300 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3132\",\"00438014\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10866",
      "DIN": "00786292",
      "Company": "BAXTER CORPORATION",
      "Product": "(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2013-01-21",
      "Original market date": "1990-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:20.00 \n \n \n \n , \n \n \n \n \n \n 40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097006",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00034399.PDF",
      "Product Monograph/Veterinary Date": "2016-04-07",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 900 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10866\",\"00786292\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10041",
      "DIN": "00438049",
      "Company": "BAXTER CORPORATION",
      "Product": "(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "2",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2013-01-21",
      "Original market date": "1989-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "2",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00 \n \n \n \n , \n \n \n \n \n \n 40:20.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0200305001",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00061808.PDF",
      "Product Monograph/Veterinary Date": "2021-03-11",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10041\",\"00438049\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9826",
      "DIN": "00786209",
      "Company": "BAXTER CORPORATION",
      "Product": "(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "2",
      "A.I. name See footnote3": "SODIUM CHLORIDE",
      "Strength": "900 MG / 100 ML",
      "Current status date": "2013-01-29",
      "Original market date": "1989-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "2",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB01 ELECTROLYTES",
      "Active ingredient group (AIG) number": "0213340001",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00049126.PDF",
      "Product Monograph/Veterinary Date": "2018-12-10",
      "List of active ingredient": "POTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 900 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9826\",\"00786209\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10043",
      "DIN": "00503142",
      "Company": "BAXTER CORPORATION",
      "Product": "(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.2% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2016-07-15",
      "Original market date": "1989-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097004",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00034399.PDF",
      "Product Monograph/Veterinary Date": "2016-04-07",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 200 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10043\",\"00503142\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10044",
      "DIN": "00437999",
      "Company": "BAXTER CORPORATION",
      "Product": "(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2013-01-21",
      "Original market date": "1989-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:20.00 \n \n \n \n , \n \n \n \n \n \n 40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097005",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00034399.PDF",
      "Product Monograph/Veterinary Date": "2016-04-07",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 450 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10044\",\"00437999\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9827",
      "DIN": "00786217",
      "Company": "BAXTER CORPORATION",
      "Product": "(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "2",
      "A.I. name See footnote3": "SODIUM CHLORIDE",
      "Strength": "900 MG / 100 ML",
      "Current status date": "2013-01-21",
      "Original market date": "1989-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "2",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB01 ELECTROLYTES",
      "Active ingredient group (AIG) number": "0213340002",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00049126.PDF",
      "Product Monograph/Veterinary Date": "2018-12-10",
      "List of active ingredient": "POTASSIUM CHLORIDE : 300 MG / 100 ML\nSODIUM CHLORIDE : 900 MG / 100 ML",
      "Dosage form": "Liquid",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=9827\",\"00786217\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10042",
      "DIN": "00438030",
      "Company": "BAXTER CORPORATION",
      "Product": "(40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "2",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2013-01-21",
      "Original market date": "1989-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "2",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00 \n \n \n \n , \n \n \n \n \n \n 40:20.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0200305003",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00061808.PDF",
      "Product Monograph/Veterinary Date": "2021-03-11",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 300 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10042\",\"00438030\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70277",
      "DIN": "02246134",
      "Company": "BAXTER CORPORATION",
      "Product": "(40 MMOLS/L) POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "4",
      "A.I. name See footnote3": "SODIUM CHLORIDE",
      "Strength": "600 MG / 100 ML",
      "Current status date": "2016-07-15",
      "Original market date": "2002-12-11",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "4",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB01 ELECTROLYTES",
      "Active ingredient group (AIG) number": "0400132004",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "CALCIUM CHLORIDE : 20 MG / 100 ML\nPOTASSIUM CHLORIDE : 328 MG / 100 ML\nSODIUM CHLORIDE : 600 MG / 100 ML\nSODIUM LACTATE : 310 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70277\",\"02246134\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3133",
      "DIN": "00438022",
      "Company": "BAXTER CORPORATION",
      "Product": "(40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "3.3 G / 100 ML",
      "Current status date": "2013-01-21",
      "Original market date": "1978-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00 \n \n \n \n , \n \n \n \n \n \n 40:20.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097002",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00034399.PDF",
      "Product Monograph/Veterinary Date": "2016-04-07",
      "List of active ingredient": "DEXTROSE : 3.3 G / 100 ML\nPOTASSIUM CHLORIDE : 300 MG / 100 ML\nSODIUM CHLORIDE : 300 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=3133\",\"00438022\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10045",
      "DIN": "00438006",
      "Company": "BAXTER CORPORATION",
      "Product": "(40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2013-01-20",
      "Original market date": "1989-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00 \n \n \n \n , \n \n \n \n \n \n 40:20.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097003",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00034399.PDF",
      "Product Monograph/Veterinary Date": "2016-04-07",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 300 MG / 100 ML\nSODIUM CHLORIDE : 450 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10045\",\"00438006\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=60161",
      "DIN": "02236871",
      "Company": "STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC.",
      "Product": "(EXTRA STRENGTH) ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE CAPLETS",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "NARCOTICS (CDSA I)",
      "# See footnote2": "3",
      "A.I. name See footnote3": "ACETAMINOPHEN",
      "Strength": "500 MG",
      "Current status date": "2002-07-31",
      "Original market date": "1998-07-22",
      "Address": "150 Beghin Avenue",
      "City": "Winnipeg",
      "state": "Manitoba",
      "Country": "Canada",
      "Zipcode": "R2J 3W2",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "28:08.92 \n \n \n \n , \n \n \n \n \n \n 28:08.08",
      "Anatomical Therapeutic Chemical (ATC)": "N02AJ06 CODEINE AND PARACETAMOL",
      "Active ingredient group (AIG) number": "0311391004",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "ACETAMINOPHEN : 500 MG\nCAFFEINE : 15 MG\nCODEINE PHOSPHATE : 8 MG",
      "Dosage form": "Tablet",
      "Route(s) of administration": "Oral",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=60161\",\"02236871\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13034",
      "DIN": "01931741",
      "Company": "B. BRAUN MEDICAL INC",
      "Product": "0.15% POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.30% SODIUM CHLORIDE INJECTION",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "3.3 G / 100 ML",
      "Current status date": "2022-06-03",
      "Original market date": "1992-12-31",
      "Address": "824 Twelfth Avenue",
      "City": "Bethlehem",
      "state": "Pennsylvania",
      "Country": "United States",
      "Zipcode": "18018",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:20.00 \n \n \n \n , \n \n \n \n \n \n 40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097001",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "DEXTROSE : 3.3 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 300 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13034\",\"01931741\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21753",
      "DIN": "01931598",
      "Company": "B. BRAUN MEDICAL INC",
      "Product": "0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "1998-10-01",
      "Original market date": "1998-09-03",
      "Address": "824 Twelfth Avenue",
      "City": "Bethlehem",
      "state": "Pennsylvania",
      "Country": "United States",
      "Zipcode": "18018",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00 \n \n \n \n , \n \n \n \n \n \n 40:20.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097004",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 200 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21753\",\"01931598\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21754",
      "DIN": "01931601",
      "Company": "B. BRAUN MEDICAL INC",
      "Product": "0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.33% SODIUM CHLORIDE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2018-07-23",
      "Original market date": "1998-09-03",
      "Address": "824 Twelfth Avenue",
      "City": "Bethlehem",
      "state": "Pennsylvania",
      "Country": "United States",
      "Zipcode": "18018",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00 \n \n \n \n , \n \n \n \n \n \n 40:20.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097022",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 330 MG / 100 ML",
      "Dosage form": "Liquid",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21754\",\"01931601\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18991",
      "DIN": "01931547",
      "Company": "B. BRAUN MEDICAL INC",
      "Product": "0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2023-03-19",
      "Original market date": "1995-12-31",
      "Address": "824 Twelfth Avenue",
      "City": "Bethlehem",
      "state": "Pennsylvania",
      "Country": "United States",
      "Zipcode": "18018",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:20.00 \n \n \n \n , \n \n \n \n \n \n 40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097005",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 450 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18991\",\"01931547\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21755",
      "DIN": "01931644",
      "Company": "B. BRAUN MEDICAL INC",
      "Product": "0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2023-03-19",
      "Original market date": "1996-09-10",
      "Address": "824 Twelfth Avenue",
      "City": "Bethlehem",
      "state": "Pennsylvania",
      "Country": "United States",
      "Zipcode": "18018",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00 \n \n \n \n , \n \n \n \n \n \n 40:20.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097006",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML\nSODIUM CHLORIDE : 900 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21755\",\"01931644\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21713",
      "DIN": "01931539",
      "Company": "B. BRAUN MEDICAL INC",
      "Product": "0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "2",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2023-03-19",
      "Original market date": "1996-09-10",
      "Address": "824 Twelfth Avenue",
      "City": "Bethlehem",
      "state": "Pennsylvania",
      "Country": "United States",
      "Zipcode": "18018",
      "Number of active ingredient(s)": "2",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:20.00 \n \n \n \n , \n \n \n \n \n \n 40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0200305001",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 150 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21713\",\"01931539\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19134",
      "DIN": "02117428",
      "Company": "PDT IMAGE INC. DBA PRO-DENTEC CANADA",
      "Product": "0.2% SODIUM FLUORIDE WEEKLY ORAL RINSE",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "NON-PRESCRIPTION DRUGS",
      "# See footnote2": "1",
      "A.I. name See footnote3": "SODIUM FLUORIDE",
      "Strength": "0.2 %",
      "Current status date": "2009-06-15",
      "Original market date": "1995-12-31",
      "Address": "UNIT 101",
      "City": "1 Valleywood Dr.",
      "state": "Markham",
      "Country": "Ontario",
      "Zipcode": "Canada",
      "Number of active ingredient(s)": "1",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "34:00.00",
      "Anatomical Therapeutic Chemical (ATC)": "A01AA01 SODIUM FLUORIDE",
      "Active ingredient group (AIG) number": "0107147012",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "SODIUM FLUORIDE : 0.2 %",
      "Dosage form": "Solution",
      "Route(s) of administration": "Dental",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19134\",\"02117428\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=23494",
      "DIN": "01967770",
      "Company": "B. BRAUN MEDICAL INC",
      "Product": "0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "2",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2017-07-15",
      "Original market date": "1998-09-03",
      "Address": "824 Twelfth Avenue",
      "City": "Bethlehem",
      "state": "Pennsylvania",
      "Country": "United States",
      "Zipcode": "18018",
      "Number of active ingredient(s)": "2",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:20.00 \n \n \n \n , \n \n \n \n \n \n 40:12.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0200305003",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 300 MG / 100 ML",
      "Dosage form": "Liquid",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=23494\",\"01967770\")"
    },
    {
      "Status": "Cancelled Post Market",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21752",
      "DIN": "01931571",
      "Company": "B. BRAUN MEDICAL INC",
      "Product": "0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION",
      "Class": "Human",
      "PM See footnote1": "No",
      "Schedule": "Ethical",
      "# See footnote2": "3",
      "A.I. name See footnote3": "DEXTROSE",
      "Strength": "5 G / 100 ML",
      "Current status date": "2023-03-19",
      "Original market date": "1998-03-08",
      "Address": "824 Twelfth Avenue",
      "City": "Bethlehem",
      "state": "Pennsylvania",
      "Country": "United States",
      "Zipcode": "18018",
      "Number of active ingredient(s)": "3",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "40:12.00 \n \n \n \n , \n \n \n \n \n \n 40:20.00",
      "Anatomical Therapeutic Chemical (ATC)": "B05BB02 ELECTROLYTES WITH CARBOHYDRATES",
      "Active ingredient group (AIG) number": "0300097003",
      "Labelling": "",
      "Product Monograph/Veterinary Date": "",
      "List of active ingredient": "DEXTROSE : 5 G / 100 ML\nPOTASSIUM CHLORIDE : 300 MG / 100 ML\nSODIUM CHLORIDE : 450 MG / 100 ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=21752\",\"01931571\")"
    },
    {
      "Status": "Marketed",
      "DIN URL": "https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10519",
      "DIN": "00828602",
      "Company": "BAXTER CORPORATION",
      "Product": "0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION",
      "Class": "Human",
      "PM See footnote1": "Yes",
      "Schedule": "Ethical",
      "# See footnote2": "2",
      "A.I. name See footnote3": "LIDOCAINE HYDROCHLORIDE",
      "Strength": "4 MG / ML",
      "Current status date": "2019-12-20",
      "Original market date": "1990-12-31",
      "Address": "7125 Mississauga Road",
      "City": "Mississauga",
      "state": "Ontario",
      "Country": "Canada",
      "Zipcode": "L5N 0C2",
      "Number of active ingredient(s)": "2",
      "Biosimilar Biologic Drug": "No",
      "American Hospital Formulary Service (AHFS)": "24:04.04.08",
      "Anatomical Therapeutic Chemical (ATC)": "C01BB01 LIDOCAINE",
      "Active ingredient group (AIG) number": "0201281001",
      "Labelling": "https://pdf.hres.ca/dpd_pm/00081137.PDF",
      "Product Monograph/Veterinary Date": "2025-07-21",
      "List of active ingredient": "DEXTROSE : 50 MG / ML\nLIDOCAINE HYDROCHLORIDE : 4 MG / ML",
      "Dosage form": "Solution",
      "Route(s) of administration": "Intravenous",
      "DIN_link_formula": "=HYPERLINK(\"https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10519\",\"00828602\")"
    }
  ]
}